We are live on
!
Find out more
BI
BVF Inc Portfolio holdings
AUM
$3.14B
1-Year Est. Return
249.53%
This Fund
S&P 500
This Quarter
Est. Return
+19.15%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.8B
AUM Growth
+$346M
(+14%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
76.91%
Holding
52
New
1
Increased
6
Reduced
7
Closed
8
Top Buys
| 1 |
Immunocore
IMCR
|
+$31.8M |
| 2 |
Protagonist Therapeutics
PTGX
|
+$30.5M |
| 3 |
CBIO
Crescent Biopharma
CBIO
|
+$27.3M |
| 4 |
Kymera Therapeutics
KYMR
|
+$11.7M |
| 5 |
Verastem
VSTM
|
+$8.17M |
Top Sells
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$36.5M |
| 2 |
VERV
Verve Therapeutics
VERV
|
+$31.6M |
| 3 |
ITOS
iTeos Therapeutics
ITOS
|
+$18.4M |
| 4 |
Xoma
XOMA
|
+$9.41M |
| 5 |
THRD
Third Harmonic Bio
THRD
|
+$8.23M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eledon Pharmaceuticals
ELDN
$310M
| $17.1M | 0.61% |
6,293,282
| – | – |
|
27
Annexon
ANNX
$1.06B
| $16.8M | 0.6% |
7,000,000
| – | – |
|
|
PVLA
28
Palvella Therapeutics
PVLA
$2.18B
| $15.7M | 0.56% |
696,555
| – | – |
|
|
EPIX
29
DELISTED
ESSA Pharma
EPIX
| $14.9M | 0.53% |
8,748,629
| – | – |
|
|
RPTX
30
DELISTED
Repare Therapeutics
RPTX
| $14.4M | 0.51% |
10,333,600
| – | – |
|
|
31
Verastem
VSTM
$504M
| $14.1M | 0.5% |
3,404,425
+1,303,957
| +62% | +$8.17M |
|
|
RAPT
32
DELISTED
RAPT Therapeutics
RAPT
| $9.24M | 0.33% |
1,154,692
-3
| -0% | -$23 |
|
33
Forte Biosciences
FBRX
$904M
| $7.61M | 0.27% |
588,344
-5,938
| -1% | -$51.1K |
|
34
TScan Therapeutics
TCRX
$60.3M
| $7.58M | 0.27% |
5,226,074
+336,600
| +7% | +$486K |
|
|
IMA
35
ImageneBio Inc
IMA
$67.8M
| $5.37M | 0.19% |
333,880
| – | – |
|
36
Immunic
IMUX
$206M
| $5.34M | 0.19% |
765,297
-125,000
| -14% | -$1.15M |
|
|
MOLN
37
Molecular Partners
MOLN
$147M
| $5.19M | 0.19% |
1,353,968
| – | – |
|
38
Avalo Therapeutics
AVTX
$975M
| $5.13M | 0.18% |
1,028,049
-8,630
| -0.8% | -$40.3K |
|
|
IVA
39
Inventiva
IVA
$1.06B
| $2.14M | 0.08% |
686,040
| – | – |
|
40
Tenax Therapeutics
TENX
$407M
| $1.98M | 0.07% |
339,549
| – | – |
|
41
SAB Biotherapeutics
SABS
$277M
| $1.61M | 0.06% |
917,826
| – | – |
|
42
Ovid Therapeutics
OVID
$465M
| $1.27M | 0.05% |
3,853,818
| – | – |
|
43
enGene Therapeutics Warrants
ENGNW
$3.44M
| $586K | 0.02% |
945,402
| – | – |
|
|
NCEL
44
NewcelX Ltd
NCEL
$21.2M
| $417K | 0.01% |
14,368
| – | – |
|
|
ALLK
45
DELISTED
Allakos
ALLK
| – | – |
-16,552,417
| Closed | -$3.77M |
|
46
CytomX Therapeutics
CTMX
$801M
| – | – |
-5,228,461
| Closed | -$3.32M |
|
|
LKFT
47
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| – | – |
-1,454,422
| Closed | -$36.5M |
|
|
ITOS
48
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-3,075,000
| Closed | -$18.4M |
|
49
NewAmsterdam Pharma
NAMS
$3.74B
| – | – |
-59,065
| Closed | -$1.21M |
|
|
THRD
50
DELISTED
Third Harmonic Bio
THRD
| – | – |
-2,372,933
| Closed | -$8.23M |
|
Similar funds
GKWIM
BP
SC
AWE
EAM
SCM
AWM
LFG